Immune response to influenza A (H1N1)v monovalent MF59-adjuvanted vaccine in HIV-infected patients

被引：27

作者：

Fabbiani, Massimiliano ^{[2
]}

Di Giambenedetto, Simona ^{[2
]}

Sali, Michela ^{[1
]}

Farina, Salvatore ^{[2
]}

Sansonetti, Paola ^{[1
,3
]}

Tamburrini, Enrica ^{[2
]}

Dal Verme, Lorenzo Zileri ^{[4
]}

Deogu, Giovanni ^{[1
]}

De Luca, Andrea ^{[2
,5
]}

Kelvin, David ^{[3
]}

Cauda, Roberto ^{[2
]}

Fadda, Giovanni ^{[1
]}

机构：

[1] Univ Cattolica Sacro Cuore, Inst Microbiol, I-00168 Rome, Italy

[2] Univ Cattolica Sacro Cuore, Inst Clin Infect Dis, I-00168 Rome, Italy

[3] Univ Hlth Network, Div Expt Therapeut, Toronto, ON, Canada

[4] Univ Cattolica Sacro Cuore, Dept Emergency Med, I-00168 Rome, Italy

[5] Siena Univ Hosp, Infect Dis Unit, Siena, Italy

来源：

VACCINE | 2011年 / 29卷 / 16期

关键词：

HIV; Influenza A (H1N1); Swine flu; Vaccination; Immunogenicity; ANTIBODY-RESPONSES; H1N1;

D O I：

10.1016/j.vaccine.2011.02.020

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

Immunogenicity of influenza A (H1N1)v MF59-adjuvanted vaccine was studied in HIV-infected patients. The vaccine was effective in inducing a protective immune response in patients with a CD4 > 200 cells/mu L while individuals with CD4 < 200 cells/mu L showed lower rates of seroconversion and seroprotection. These results underscore the usefulness of immunization against influenza in HIV-infected patients, though a boosting dose of vaccine may be required in seriously immunocompromised patients. (C) 2011 Elsevier Ltd. All rights reserved.

引用

页码：2836 / 2839

页数：4

共 14 条

[1] Influenza vaccination of HIV-1-positive and HIV-1-negative former intravenous drug users [J].

Amendola, A ;

Boschini, A ;

Colzani, D ;

Anselmi, G ;

Oltolina, A ;

Zucconi, R ;

Begnini, M ;

Besana, S ;

Tanzi, E ;

Zanetti, AR .

JOURNAL OF MEDICAL VIROLOGY, 2001, 65 (04) :644-648

[2] Low rate of seroconversion after vaccination with a split virion, adjuvanted pandemic H1N1 influenza vaccine in HIV-1-infected patients [J].

Bickel, Markus ;

Wieters, Imke ;

Khaykin, Pavel ;

Nisius, Gabi ;

Haberl, Annette ;

Stephan, Christoph ;

Von Hentig, Nils ;

Herrmann, Eva ;

Doerr, Hans W. ;

Brodt, Hans R. ;

Allwinn, Regina .

AIDS, 2010, 24 (09) :F31-F35

[3] Trial of 2009 Influenza A (H1N1) Monovalent MF59-Adjuvanted Vaccine. [J].

Clark, Tristan W. ;

Pareek, Manish ;

Hoschler, Katja ;

Dillon, Helen ;

Nicholson, Karl G. ;

Groth, Nicola ;

Stephenson, Iain .

NEW ENGLAND JOURNAL OF MEDICINE, 2009, 361 (25) :2424-2435

[4]

Anonymous, 2006, Morbidity and Mortality Weekly Report, V55, P1

[5]

*FOC, SUMM PROD CHAR

[6] Immunologic and virologic evaluation after influenza vaccination of HIV-1-infected patients [J].

Fowke, KR ;

DAmico, R ;

Chernoff, DN ;

Pottage, JC ;

Benson, CA ;

Sha, BE ;

Kessler, HA ;

Landay, AL ;

Shearer, GM .

AIDS, 1997, 11 (08) :1013-1021

[7] Cross-Reactive Antibody Responses to the 2009 Pandemic H1N1 Influenza Virus. [J].

Hancock, Kathy ;

Veguilla, Vic ;

Lu, Xiuhua ;

Zhong, Weimin ;

Butler, Ebonee N. ;

Sun, Hong ;

Liu, Feng ;

Dong, Libo ;

DeVos, Joshua R. ;

Gargiullo, Paul M. ;

Brammer, T. Lynnette ;

Cox, Nancy J. ;

Tumpey, Terrence M. ;

Katz, Jacqueline M. .

NEW ENGLAND JOURNAL OF MEDICINE, 2009, 361 (20) :1945-1952

[8] Antibody responses and HIV-1 viral load in HIV-1-seropositive subjects immunised with either the MF59-adjuvanted influenza vaccine or a conventional non-adjuvanted subunit vaccine during highly active antiretroviral therapy [J].

Iorio, AM ;

Francisci, D ;

Camilloni, B ;

Stagni, G ;

De Martino, M ;

Toneatto, D ;

Bugarini, R ;

Neri, M ;

Podda, A .

VACCINE, 2003, 21 (25-26) :3629-3637

[9]

Kendal A.P., 1982, CONCEPTS PROCEDURES, pB17

[10] Influenza in immunosuppressed populations: a review of infection frequency, morbidity, mortality, and vaccine responses [J].

Kunisaki, Ken M. ;

Janoff, Edward N. .

LANCET INFECTIOUS DISEASES, 2009, 9 (08) :493-504

← 1 2 →